Cardiovascular risk factors regulate the expression of vascular endothelin receptors
- 31 August 2010
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 127 (2), 148-155
- https://doi.org/10.1016/j.pharmthera.2010.04.013
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart diseaseBMC Cardiovascular Disorders, 2009
- Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cellsBMC Cell Biology, 2009
- The Raf-1 inhibitor GW5074 and dexamethasone suppress sidestream smoke-induced airway hyperresponsiveness in miceRespiratory Research, 2008
- Contrasting Actions of Endothelin ETAand ETBReceptors in Cardiovascular DiseaseAnnual Review of Pharmacology and Toxicology, 2007
- Smoking and ischemic stroke: a role for nicotine?Trends in Pharmacological Sciences, 2002
- Subtype-Specific Desensitization of Human Endothelin ETA and ETB Receptors Reflects Differential Receptor PhosphorylationBiochemistry, 1997
- Subtypes of Endothelin ETA and ETB Receptors Mediating Venous Smooth Muscle ContractionBiochemical and Biophysical Research Communications, 1994
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Cloning and characterization of cDNA encoding human a-type endothelin receptorBiochemical and Biophysical Research Communications, 1991